Ambalal Sarabhai Enterprises P/E Ratio
Ambalal Sarabhai Enterprises (AMBALALSA) P/E ratio is not applicable — EPS (TTM) ₹0.64, 2 consecutive loss quarters. See Healthcare peers with valid P/E ratios below.
P/E Ratio Status
N/A
Loss Making
Company is currently reporting losses
P/E Ratio Not Applicable
Company has reported losses in the last 2 quarters. P/E ratio is not applicable during loss periods.
Consecutive Loss Quarters: 2
Current EPS: ₹0.64
Recent Quarterly Performance
| Quarter | EPS (₹) | Net Profit (₹ Cr) | Status |
|---|---|---|---|
| Sept 2025 | -0.07 | -1 | Loss |
| Mar 2025 | -0.04 | 0 | Loss |
| Jun 2025 | 1.07 | 8 | Profit |
| Dec 2025 | 0.40 | 4 | Profit |
| Sept 2024 | 0.34 | 3 | Profit |
| Mar 2024 | 1.18 | 9 | Profit |
| Jun 2024 | 0.05 | 0 | Profit |
| Dec 2024 | 0.29 | 2 | Profit |
Healthcare Peers with Valid P/E Ratios — AMBALALSA Comparison
Healthcare sector average P/E 50.03, median 29.4 — AMBALALSA excluded (negative EPS).
Sector Average PE
50.03
Sector Median PE
29.4
Lowest PE
1.0
Profitable Companies
190
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 1.0 | ₹36 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 3.45 | ₹61 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 4.69 | ₹1,161 | Low |
| Amwill Health Care | AMWILL | 6.34 | ₹65 | Low |
| Brooks Laboratories | BROOKS | 6.6 | ₹137 | Low |
| Mono Pharmacare | MONOPHARMA | 7.1 | ₹21 | Low |
| Shelter Pharma | SHELTER | 7.4 | ₹54 | Low |
| Medicamen Organics | MEDIORG | 7.51 | ₹32 | Low |
| Zenith Drugs | ZENITHDRUG | 7.69 | ₹66 | Low |
Related Analysis
- For live price, revenue and the complete fundamental profile, see AMBALALSA share price screener.
- Browse AMBALALSA annual financials for revenue, profit, balance sheet and cash flow data.
- Analyse AMBALALSA shareholder distribution to track promoter, FII and institutional holdings.